SEC Form 4 · accession 0001127602-18-008948
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 7:16 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2018 | S | 100 | $108.495 | D | 14,515 | D | |
| Common Stock | Feb 26, 2018 | S | 119 | $108.50 | D | 14,396 | D | |
| Common Stock | Feb 26, 2018 | S | 100 | $108.59 | D | 14,296 | D | |
| Common Stock | Feb 27, 2018 | F | 218 | $108.95 | D | 14,078 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.